PT Kalbe Farma Tbk. (PTKFF)

USD 0.08

(0.0%)

Gross Profit Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual gross profit in 2023 was 743.47 Million USD , up 2.65% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly gross profit in 2024 Q3 was 194.33 Million USD , up 1650787.46% from previous quarter.
PT Kalbe Farma Tbk. reported a annual gross profit of 724.27 Million USD in annual gross profit 2022, down -5.05% from previous year.
PT Kalbe Farma Tbk. reported a annual gross profit of 762.79 Million USD in annual gross profit 2021, up 8.48% from previous year.
PT Kalbe Farma Tbk. reported a quarterly gross profit of 194.33 Million USD for 2024 Q3, up 1650787.46% from previous quarter.
PT Kalbe Farma Tbk. reported a quarterly gross profit of 202.77 Million USD for 2024 Q1, up 10.62% from previous quarter.

Annual Gross Profit Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Gross Profit of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	743.47 Million USD	2.65%
2022	724.27 Million USD	-5.05%
2021	762.79 Million USD	8.48%
2020	703.15 Million USD	-1.85%
2019	716.38 Million USD	7.71%
2018	665.12 Million USD	-5.32%
2017	702.49 Million USD	2.22%
2016	687.21 Million USD	13.12%
2015	607.48 Million USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	184.89 Million USD	-8.81%
2024 Q3	194.33 Million USD	1650787.46%
2024 Q1	202.77 Million USD	10.62%
2023 Q4	183.29 Million USD	6.69%
2023 FY	743.47 Million USD	2.65%
2023 Q1	206.22 Million USD	12.05%
2023 Q2	191.27 Million USD	-7.25%
2023 Q3	171.8 Million USD	-10.18%
2022 Q2	185.57 Million USD	-5.12%
2022 FY	724.27 Million USD	-5.05%
2022 Q4	184.05 Million USD	-0.17%
2022 Q3	184.36 Million USD	-0.65%
2022 Q1	195.6 Million USD	-3.81%
2021 Q1	175.24 Million USD	0.0%
2021 FY	762.79 Million USD	8.48%
2021 Q4	203.35 Million USD	4.25%
2021 Q3	195.07 Million USD	6.34%
2021 Q2	183.43 Million USD	4.67%
2020 FY	703.15 Million USD	-1.85%
2019 FY	716.38 Million USD	7.71%
2018 FY	665.12 Million USD	-5.32%
2017 FY	702.49 Million USD	2.22%
2016 FY	687.21 Million USD	13.12%
2015 FY	607.48 Million USD	0.0%

Peer Gross Profit Comparison of PT Kalbe Farma Tbk.

Name	Gross Profit	Gross Profit Difference
AstraZeneca PLC	34.69 Billion USD	97.857%
Bristol-Myers Squibb Company PFD CONV 2	34.31 Billion USD	97.833%
CSPC Pharmaceutical Group Limited	30.13 Billion USD	97.533%
Clarus Therapeutics Holdings, Inc.	11.23 Million USD	-6516.296%
Novartis AG	34.18 Billion USD	97.825%